Pharma News
UK drug shortages are far from being solved
Despite attempts to solve problems with shortages of brand-name medicines in the UK, the issue is taking up more of pharmacists’ time, is far from being solved and may be getting worse according to an online stock survey carried out by pharmacists organisation Chemist+Druggist.
Drug shortage woes continue in the UK
Despite attempts to solve problems with shortages of brand-name medicines in the UK, the issue is far from beings resolved. The latest news is that the UK’s wholesalers have called for a ‘third-party monitoring and survey service’ to help tackle medicines shortages, while the Association of the British Pharmaceutical Industry (ABPI) is calling for sanctions on pharmacists that act as wholesalers.
Shortages of ADHD drugs expected during 2012
Drugs used to treat attention deficit hyperactivity disorder (ADHD) are in such short supply that FDA has reported that it receives hundreds of complaints from patients unable to fill their prescriptions.
UK drug shortages continue to affect pharmacists and patients
Shortages of brand-name medicines are as much of a problem in 2011 as they were in 2010, according to a survey by the Pharmaceutical Services Negotiating Committee (PSNC).
Hospira’s manufacturing troubles may add to drug shortages
Injectable generics specialist, Hospira, is under scrutiny again regarding drug shortages caused by its continuing lack of compliance with FDA requirements. In fact, one analyst from The Wall Street believes that the company has production problems that require long-term attention and that could lead to it receiving a consent decree from FDA.
Biosimilars and cancer drug shortages in Europe
With all the talk about drug shortages in the US it might be easy to forget the rest of the world, but it seems that drug shortages are also hitting European countries and are affecting not just generics, but also biosimilars.
Members of parliament to hold inquiry into UK drug shortages
On 21 November 2011, a group of UK members of parliament (MPs) announced that they will hold a full-scale inquiry into the continuing problem of drug shortages within the National Health Service (NHS).
Some relief from drug shortages in the US
There finally appears to be some light at the end of the tunnel, with one of the main victims of shortages—the sterile injectable drug propofol—finally being declared no longer in short supply by FDA.
Obama’s fresh attempts to ease drugs shortages in the US
Action by the President
President Barack Obama signed an executive order 31 October 2011 to address an escalating shortage of life-saving medicines, his newest effort to advance social and economic measures that have stalled in Congress.
Cancer drug shortages in the US
There is concern being expressed about the growing number of drug shortages among essential and lifesaving cancer drugs.
